Infusion pump

Infusion Pump Market Worth $18.9 Billion by 2025 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Thursday, March 19, 2020

Based on products, the infusion pumps market is segmented into accessories & consumables and devices.

Key Points: 
  • Based on products, the infusion pumps market is segmented into accessories & consumables and devices.
  • Based on product, the infusion pumps market is segmented into dedicated accessories & consumables and non-dedicated accessories & consumables.
  • Based on type, the infusion pump devices market has been segmented into traditional infusion pumps and specialty infusion pumps market.
  • North America accounted for the largest share of the infusion pumps market in 2019, followed by Europe.

Infusion Pump Market Worth $18.9 Billion by 2025 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Thursday, March 19, 2020

Based on products, the infusion pumps market is segmented into accessories & consumables and devices.

Key Points: 
  • Based on products, the infusion pumps market is segmented into accessories & consumables and devices.
  • Based on product, the infusion pumps market is segmented into dedicated accessories & consumables and non-dedicated accessories & consumables.
  • Based on type, the infusion pump devices market has been segmented into traditional infusion pumps and specialty infusion pumps market.
  • North America accounted for the largest share of the infusion pumps market in 2019, followed by Europe.

IRADIMED CORPORATION Announces the Appointment of Lynn Neuhardt as Vice President of Research and Development

Retrieved on: 
Thursday, March 12, 2020

WINTER SPRINGS, Fla., March 12, 2020 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced the appointment of Lynn Neuhardt as Vice President of Research and Development, effective March 26, 2020.

Key Points: 
  • WINTER SPRINGS, Fla., March 12, 2020 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced the appointment of Lynn Neuhardt as Vice President of Research and Development, effective March 26, 2020.
  • Lynn will lead our talented R&D team and collaborate closely with Roger Susi, our founder and Chief Technology Officer.
  • Prior to his appointment at IRADIMED, Mr. Neuhardt spent 4 years at ICU Medical, Inc. as a Director of Systems and Test Engineering.
  • Mr. Neuhardt is experienced in the development of IV infusion pumps and in all phases of new product development.

The global elastomer infusion pump market was valued at $534 million in 2018, and is estimated to reach at $745 million by 2026, registering a CAGR of 4.2% from 2019 to 2026

Retrieved on: 
Monday, March 9, 2020

These pumps provide advanced benefits over conventional infusion pump in features such as portability, feasibility, and less scope for human errors.

Key Points: 
  • These pumps provide advanced benefits over conventional infusion pump in features such as portability, feasibility, and less scope for human errors.
  • There are two types of elastomer infusion pumps that include continuous rate pumps, and variable rate pumps.
  • Such advantages of elastomer infusion pumps over conventional electric infusion pump are expected to drive the growth of the market.
  • However, low income and lack of proper medical attention in the developing countries hamper the growth of the elastomer infusion pump market.

Elastomer Infusion Pump Market to Reach $745.1 Mn, Globally, by 2026 at 4.2% CAGR: Allied Market Research

Retrieved on: 
Monday, February 17, 2020

According to the report, the global elastomer infusion pump industry generated $533.8 million in 2018 and is expected to hit $745.1 million by 2026, registering a CAGR of 4.2% from 2019 to 2026.

Key Points: 
  • According to the report, the global elastomer infusion pump industry generated $533.8 million in 2018 and is expected to hit $745.1 million by 2026, registering a CAGR of 4.2% from 2019 to 2026.
  • Increase in burden on hospitals to reduce healthcare costs, emergence of novel elastomer infusion pumps, and user-friendly nature of the same fuel the growth of the global elastomer infusion pump market.
  • Based on product, the continuous red pumps segment accounted for nearly three-fifths of the global elastomer infusion pump market share in 2018, and is expected to rule the roost by the end of 2026.
  • Based on application, the pain management segment held the highest share in 2018, garnering one-third of the global elastomer infusion pump market.

Elastomer Infusion Pump Market to Reach $745.1 Mn, Globally, by 2026 at 4.2% CAGR: Allied Market Research

Retrieved on: 
Monday, February 17, 2020

According to the report, the global elastomer infusion pump industry generated $533.8 million in 2018 and is expected to hit $745.1 million by 2026, registering a CAGR of 4.2% from 2019 to 2026.

Key Points: 
  • According to the report, the global elastomer infusion pump industry generated $533.8 million in 2018 and is expected to hit $745.1 million by 2026, registering a CAGR of 4.2% from 2019 to 2026.
  • Increase in burden on hospitals to reduce healthcare costs, emergence of novel elastomer infusion pumps, and user-friendly nature of the same fuel the growth of the global elastomer infusion pump market.
  • Based on product, the continuous red pumps segment accounted for nearly three-fifths of the global elastomer infusion pump market share in 2018, and is expected to rule the roost by the end of 2026.
  • Based on application, the pain management segment held the highest share in 2018, garnering one-third of the global elastomer infusion pump market.

KORU Medical Systems to Ring Nasdaq Closing Bell on February 12, 2020

Retrieved on: 
Monday, February 10, 2020

Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ:KRMD) (KORU Medical or the Company) today announced that Don Pettigrew, President & CEO, will ring the Nasdaq Closing Bell on Wednesday, February 12, 2020 at 4:00 pm ET.

Key Points: 
  • Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ:KRMD) (KORU Medical or the Company) today announced that Don Pettigrew, President & CEO, will ring the Nasdaq Closing Bell on Wednesday, February 12, 2020 at 4:00 pm ET.
  • We are honored to ring the closing bell in celebration of our recent uplisting to Nasdaq, our corporate re-branding to KORU Medical Systems, and our position as a market leader of innovative and easy-to-use specialty infusion devices, said Mr. Pettigrew.
  • KORU Medical Systems develops, manufactures and commercializes innovative and easy-to-use specialty infusion solutions that improve quality of life for patients around the world.
  • Actual results, performance or events may differ materially from those expressed or implied in such forward-looking statements.

Bainbridge Health Will Provide Children's Mercy Kansas City with Its Med O.S.© Infusion Pump Platform to Ensure the Safe Use of IV Medications

Retrieved on: 
Tuesday, January 28, 2020

Through the partnership, Bainbridge Health will provide Children's Mercy with its Med O.S.

Key Points: 
  • Through the partnership, Bainbridge Health will provide Children's Mercy with its Med O.S.
  • Infusion Pump Safety Solution to enhance visibility on medication use data and prevent avoidable harm associated with medication errors.
  • Bainbridge Health remains committed to preventing medication errors and ensuring the safety of all those who seek care.
  • Platform organizes and analyzes infusion pump data to help clinicians better understand how medications are being administered to patients and inform quality improvement initiatives.

Global Programmable Infusion Pumps Market will Grow with a CAGR of Almost 8% During the Forecast Period, 2020-2024 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 15, 2020

The "Programmable Infusion Pumps Market by Distribution Channel, Product, and Geography - Forecast and Analysis 2020-2024" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Programmable Infusion Pumps Market by Distribution Channel, Product, and Geography - Forecast and Analysis 2020-2024" report has been added to ResearchAndMarkets.com's offering.
  • Global Programmable Infusion Pumps Market: About this market
    The programmable infusion pumps market analysis considers sales from large-volume infusion pumps and small-volume infusion pumps.
  • However, high costs associated with programmable infusion pumps, availability of alternative drug delivery methods, and frequent product recalls may hamper the growth of the programmable infusion pumps industry over the forecast period.
  • Companies operating in the global programmable infusion pumps market are focusing on developing ambulatory programmable drug infusion pumps to administer medications in home-care settings.

Global Programmable Infusion Pumps Market 2020-2024| Evolving Opportunities with ICU Medical Inc. and B. Braun Melsungen AG | Technavio

Retrieved on: 
Monday, January 6, 2020
Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20200106005652/en/
    Technavio has announced its latest market research report titled global programmable infusion pumps market 2020-2024 (Photo: Business Wire)
    Read the 159-page research report with TOC on "Programmable Infusion Pumps Market Analysis Report by Geography (Asia, Europe, North America, and ROW), by Type (Large-volume infusion pumps and Small-volume infusion pumps), and Segment Forecasts, 2020-2024".
  • Computerized ambulatory programmable drug infusion pumps are gaining prominence in home-care settings for administration of antibiotics and various other drugs.
  • Major Five Programmable Infusion Pumps Market Companies:
    B. Braun Melsungen AG is headquartered in Germany and operates the business under various segments such as B. Braun Hospital Care, B. Braun Aesculap, B. Braun Out Patient Market, and B. Braun Avitum.
  • Chemotherapy Infusion Pumps Market Global Chemotherapy Infusion Pumps Market by product (LVPs and syringe pumps and elastomeric pumps) and geography (Asia, Europe, North America, and ROW).